Cargando…

Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study

BACKGROUND: Chronic kidney disease (CKD) is a rising public health problem that may progress to kidney failure, requiring kidney replacement therapy. It is also associated with an increased incidence of cardiovascular disease (CVD). Because of its asymptomatic nature, CKD is often detected in a late...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Mil, Dominique, Kieneker, Lyanne M., Evers-Roeten, Birgitte, Thelen, Marc H. M., de Vries, Hanne, Hemmelder, Marc H., Dorgelo, Annemiek, van Etten, Ronald W., Heerspink, Hiddo J. L., Gansevoort, Ron T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778938/ https://www.ncbi.nlm.nih.gov/pubmed/36548281 http://dx.doi.org/10.1371/journal.pone.0279321

Ejemplares similares

Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project
por: Luo, Li, et al.
Publicado: (2023)

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
por: Hellemons, Merel E., et al.
Publicado: (2012)

How to measure and monitor albuminuria in healthy toddlers?
por: van den Belt, Sophie Marielle, et al.
Publicado: (2018)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Longitudinal relationship between albuminuria in infancy and childhood
por: Gracchi, Valentina, et al.
Publicado: (2023)

Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2020)

Albuminuria as a marker of systemic congestion in patients with heart failure
por: Boorsma, Eva M, et al.
Publicado: (2022)

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016)

Albuminuria and markers for cardiovascular risk in 12-year-olds from the general Dutch population: a cross-sectional study
por: Gracchi, Valentina, et al.
Publicado: (2023)

Determining the optimal dose of atrasentan by evaluating the exposure‐response relationships of albuminuria and bodyweight
por: Koomen, Jeroen V., et al.
Publicado: (2018)

HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021)

The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
por: van Raalte, Daniël H., et al.
Publicado: (2019)

Combined low vitamin D and K status amplifies mortality risk: a prospective study
por: van Ballegooijen, Adriana J., et al.
Publicado: (2020)

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population
por: Taylor, Jacob M., et al.
Publicado: (2016)

Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology
por: Waijer, Simke W., et al.
Publicado: (2022)

Erratum to: COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
por: Hilbrands, Luuk B, et al.
Publicado: (2021)

Kidney function, albuminuria and life expectancy
por: Turin, Tanvir Chowdhury, et al.
Publicado: (2014)

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58
por: Mosenzon, Ofri, et al.
Publicado: (2021)

Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials
por: van der Aart ‐ van der Beek, Annemarie B., et al.
Publicado: (2020)

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
por: Gant, Christina M., et al.
Publicado: (2017)

Reduction in albuminuria with dapagliflozin cannot be predicted by baseline clinical characteristics or changes in most other risk markers
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
por: Slagman, Maartje C J, et al.
Publicado: (2011)

Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort
por: Scheven, Lieneke, et al.
Publicado: (2013)

An integrated approach towards a public health perspective on chronic kidney disease
por: Dorgelo, Annemiek, et al.
Publicado: (2022)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study
por: Bourgonje, Martin F., et al.
Publicado: (2023)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
por: Van Raalte, Daniel H., et al.
Publicado: (2022)

Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018)

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models
por: van den Brand, Jan A. J. G., et al.
Publicado: (2019)

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk
por: Dronkers, Just, et al.
Publicado: (2022)

The Association of Albuminuria With Tubular Reabsorption of Uric Acid: Results From a General Population Cohort
por: Scheven, Lieneke, et al.
Publicado: (2014)

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial
por: Curovic, Viktor Rotbain, et al.
Publicado: (2023)

Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial
por: Mosenzon, Ofri, et al.
Publicado: (2020)

Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials
por: Heerspink, Hiddo J.L., et al.
Publicado: (2023)

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial
por: Persson, Frederik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kasdd16tpgrp6pmplkc3e6mahm